I

Ironwood Pharmaceuticals
D

IRWD

3.36000
USD
-0.06
(-1.75%)
Market Closed
Volume
108,720
EPS
1
Div Yield
-
P/E
-336
Market Cap
537,695,384
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    More
News

Title: Ironwood Pharmaceuticals

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses,commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.